SCHEMBL3822281

SCHEMBL3822281

NCc1nnc(-c2cccc(F)c2)o1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 4/20 0.65
PTK2 Q05397 1/20 0.55
TAAR1 Q96RJ0 2/20 0.49
TSHR P16473 2/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
GSK3B P49841 2/20 0.45
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
MECP2 P51608 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
GUSB P08236 1/20 0.42
HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3827046 0.88 NOTUM (0.55) NOTUMPTK2TAAR1ALDH1A1LMNA
SCHEMBL27475342 0.84 ALDH1A1 (0.65) NOTUMPTK2TSHRUSP2POLB
SCHEMBL31413771 0.84 ALDH1A1 (0.65) NOTUMPTK2TSHRUSP2POLB
SCHEMBL13933384 0.81 NOTUM (0.65) NOTUMTSHRPOLBALDH1A1LMNA
SCHEMBL3822202 0.81 NOTUM (0.65) NOTUMTSHRPOLBALDH1A1LMNA
SCHEMBL3821263 0.81 NOTUM (0.65) NOTUMPTK2TAAR1TSHRALDH1A1
SCHEMBL4652480 0.79 NOTUM (1.00) NOTUMTSHRPOLBALDH1A1LMNA
SCHEMBL27269556 0.78 NOTUM (0.61) NOTUMPTK2TAAR1POLBALDH1A1
SCHEMBL30966748 0.78 NOTUM (0.61) NOTUMPTK2TAAR1POLBALDH1A1
SCHEMBL3825063 0.77 KDM4E (0.67) NOTUMPTK2TSHRPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 NOTUM 298/4885PTK2 2750/4885TAAR1 4786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.